Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GOSS Gossamer Bio Inc.

盘前交易 01-22 04:19:48 EST

2.74

+0.14

+5.38%

最高2.76	最低2.56	成交量633.77万
今开2.60	昨收2.60	日振幅7.50%
总市值6.34亿	流通市值5.04亿	总股本2.31亿
成交额1,702万	换手率3.45%	流通股本1.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GOSS","market":"US","secType":"STK","nameCN":"Gossamer Bio Inc.","latestPrice":2.74,"timestamp":1769029200000,"preClose":2.6,"halted":0,"volume":6337717,"delay":0,"changeRate":0.05384615384615389,"floatShares":183824329,"shares":231456247,"eps":-0.687408,"marketStatus":"盘前交易","change":0.14,"latestTime":"01-22 04:19:48 EST","open":2.6,"high":2.755,"low":2.56,"amount":17017524.333322998,"amplitude":0.075,"askPrice":3.19,"askSize":100,"bidPrice":2.52,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.687408,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769092200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1549602000000,"exchange":"NASDAQ","adjPreClose":2.74,"postHourTrading":{"tag":"盘后","latestPrice":2.8,"preClose":2.74,"latestTime":"19:54 EST","volume":167481,"amount":468626.0067,"timestamp":1769043293168,"change":0.06,"changeRate":0.021898,"amplitude":0.058394},"volumeRatio":1.659514375914089,"impliedVol":3.6123,"impliedVolPercentile":0.948},"requestUrl":"/m/hq/s/GOSS","defaultTab":"news","newsList":[{"id":"2601360600","title":"Gossamer Bio, Inc.盘中异动 下午盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601360600","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601360600?lang=zh_cn&edition=full","pubTime":"2026-01-08 02:21","pubTimestamp":1767810082,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日02时21分，Gossamer Bio, Inc.股票出现波动，股价快速下跌5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为2.18%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Monte Rosa Therapeutics, Inc.、Novabay Pharmaceuticals, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Aspire Biopharma Holdings, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为1082.60%、332.28%、286.69%，振幅较大的相关个股有Moolec Science Sa C/Wts 30/01/2028、Novabay Pharmaceuticals, Inc.、Aspire Biopharma Holdings, Inc.，振幅分别为50.85%、50.20%、41.43%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010802212297a13560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010802212297a13560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2600609754","title":"Gossamer Bio, Inc.盘中异动 早盘股价大跌5.03%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600609754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600609754?lang=zh_cn&edition=full","pubTime":"2026-01-02 23:08","pubTimestamp":1767366510,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日23时08分，Gossamer Bio, Inc.股票出现波动，股价急速下跌5.03%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Jasper Therapeutics Inc C/Wts 24/09/2026 、Pepgen Inc.、Geovax Labs, Inc.涨幅较大，Can Fite Biopharma Ltd、Outlook Therapeutics, Inc.、Sensei Biotherapeutics, Inc.较为活跃，换手率分别为82.97%、54.56%、52.39%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为45.14%、34.51%、21.34%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102230830a6ebfbba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102230830a6ebfbba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","GOSS","BK4139"],"gpt_icon":0},{"id":"2593428874","title":"Gossamer Bio, Inc.盘中异动 急速跳水5.04%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593428874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593428874?lang=zh_cn&edition=full","pubTime":"2025-12-23 23:03","pubTimestamp":1766502188,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日23时03分，Gossamer Bio, Inc.股票出现波动，股价快速下挫5.04%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Lexaria Bioscience Corp.、Pmgc Holdings Inc.、Reviva Pharmaceuticals Holdings, Inc.较为活跃，换手率分别为63.57%、25.39%、23.66%，振幅较大的相关个股有Geovax Labs, Inc.、健永生技、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为34.42%、32.32%、27.78%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230309a6c6775a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223230309a6c6775a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2592917616","title":"Gossamer Bio, Inc.盘中异动 早盘股价大涨5.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592917616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592917616?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:32","pubTimestamp":1765981951,"startTime":"0","endTime":"0","summary":"北京时间2025年12月17日22时32分，Gossamer Bio, Inc.股票出现异动，股价快速拉升5.90%。截至发稿，该股报3.77美元/股，成交量13.972万股，换手率0.06%，振幅3.37%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Vyne Therapeutics Inc.、Aditxt, Inc.涨幅较大，Pmgc Holdings Inc.、Aditxt, Inc.、Vyne Therapeutics Inc.较为活跃，换手率分别为1010.00%、913.38%、244.12%，振幅较大的相关个股有Aditxt, Inc.、Vyne Therapeutics Inc.、Mindwalk Holdings Corp.，振幅分别为14.79%、13.36%、11.31%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722323197a06e75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121722323197a06e75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2588909825","title":"Gossamer Bio, Inc.盘中异动 急速下挫5.10%报2.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588909825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588909825?lang=zh_cn&edition=full","pubTime":"2025-12-03 04:40","pubTimestamp":1764708012,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日04时40分，Gossamer Bio, Inc.股票出现波动，股价快速下挫5.10%。截至发稿，该股报2.98美元/股，成交量283.654万股，换手率1.23%，振幅4.94%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Polyrizon Ltd.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Moolec Science Sa涨幅较大，Polyrizon Ltd.、Clearmind Medicine Inc.、Jasper Therapeutics, Inc.较为活跃，换手率分别为13714.42%、348.46%、202.94%，振幅较大的相关个股有Polyrizon Ltd.、Akari Therapeutics Plc、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为79.43%、70.43%、63.55%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120304401295275148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120304401295275148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"1162764197","title":"Gossamer Bio宣布根据纳斯达克上市规则5635(C)(4)提供诱导授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1162764197","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162764197?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:12","pubTimestamp":1763572330,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc. ::*GOSSAMER BIO宣布根据纳斯达克上市规则5635(C)(4)提供诱导授予","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0},{"id":"2574345580","title":"Gossamer Bio, Inc.盘中异动 早盘快速跳水5.08%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574345580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574345580?lang=zh_cn&edition=full","pubTime":"2025-10-10 21:51","pubTimestamp":1760104303,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日21时51分，Gossamer Bio, Inc.股票出现异动，股价快速下跌5.08%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Gyre Therapeutics, Inc.、Atyr Pharma, Inc.涨幅较大，Aditxt, Inc.、Cdt Equity Inc.、Intensity Therapeutics, Inc.较为活跃，换手率分别为292.50%、50.70%、38.15%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Cabaletta Bio, Inc.、Intensity Therapeutics, Inc.，振幅分别为39.27%、18.59%、16.83%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102151439726a8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510102151439726a8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GOSS","BK4505"],"gpt_icon":0},{"id":"2572650461","title":"Gossamer Bio, Inc.盘中异动 大幅上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572650461","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572650461?lang=zh_cn&edition=full","pubTime":"2025-10-03 21:33","pubTimestamp":1759498394,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日21时33分，Gossamer Bio, Inc.股票出现异动，股价快速拉升5.23%。截至发稿，该股报2.61美元/股，成交量9.1675万股，换手率0.04%，振幅4.03%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Ovid Therapeutics Inc.、Reviva Pharmaceuticals Holdings, Inc.涨幅较大，Ovid Therapeutics Inc.、Palisade Bio, Inc.、Alto Neuroscience, Inc.较为活跃，换手率分别为42.99%、29.15%、13.65%，振幅较大的相关个股有Palisade Bio, Inc.、Neurogene Inc.、Yd Bio Limited，振幅分别为14.71%、11.82%、10.12%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213314a6ac2d79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003213314a6ac2d79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2572587727","title":"Gossamer Bio, Inc.盘中异动 快速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572587727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572587727?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:05","pubTimestamp":1759241131,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日22时05分，Gossamer Bio, Inc.股票出现波动，股价大幅下跌5.32%。截至发稿，该股报2.67美元/股，成交量27.0992万股，换手率0.12%，振幅6.02%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Scisparc Ltd.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Anaptysbio, Inc.涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1742.43%、285.41%、256.74%，振幅较大的相关个股有Scisparc Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Anaptysbio, Inc.，振幅分别为28.48%、26.06%、24.54%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220531a6a894f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220531a6a894f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"1154713854","title":"Respira Therapeutics与Gossamer Bio Inc.达成协议，Gossamer Bio获得从Samsara Biocapital收购Respira的选择权","url":"https://stock-news.laohu8.com/highlight/detail?id=1154713854","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154713854?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:41","pubTimestamp":1758800508,"startTime":"0","endTime":"0","summary":"Respira Therapeutics与Gossamer Bio Inc.达成协议，授予Gossamer Bio从Samsara Biocapital收购Respira的选择权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"1195142945","title":"Gossamer Bio Inc - 若期权获得行使，公司预计RT234临床试验最早将于2027年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1195142945","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195142945?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:35","pubTimestamp":1758800120,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc表示，如果期权得到行使，公司预计不会在2027年之前启动RT234的临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"1140821658","title":"Gossamer Bio：Respira股东有资格获得部分里程碑付款及Rt234潜在净销售额的高个位数特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1140821658","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140821658?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:34","pubTimestamp":1758800089,"startTime":"0","endTime":"0","summary":"Gossamer Bio宣布，Respira的股东有资格获得部分里程碑付款，以及Rt234潜在净销售额的高个位数特许权使用费。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"1199232920","title":"Gossamer Bio Inc.签署期权协议，拟收购Respira Therapeutics及其核心候选药物Rt234——一款用于肺动脉高压的按需吸入式伐地那非","url":"https://stock-news.laohu8.com/highlight/detail?id=1199232920","media":"美股速递","labels":["corporation","productRelease","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199232920?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:31","pubTimestamp":1758799900,"startTime":"0","endTime":"0","summary":"Gossamer Bio Inc.已与Respira Therapeutics达成期权协议，计划收购该公司及其主要候选药物Rt234。Rt234是一款创新的按需吸入式伐地那非药物，专门用于治疗肺动脉高压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2568832992","title":"Gossamer Bio, Inc.盘中异动 早盘快速拉升5.02%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568832992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568832992?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:48","pubTimestamp":1758203285,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时48分，Gossamer Bio, Inc.股票出现波动，股价大幅拉升5.02%。截至发稿，该股报3.14美元/股，成交量39.644万股，换手率0.17%，振幅3.85%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，89Bio, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.涨幅较大，Aptevo Therapeutics Inc.、Psyence Biomedical Ltd.、Biocardia, Inc.较为活跃，换手率分别为2072.35%、917.35%、270.64%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Replimune Group, Inc.，振幅分别为52.69%、31.72%、22.59%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214805a4cddcfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214805a4cddcfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2558068485","title":"Gossamer Bio, Inc.2025财年第二财季实现净利润-38.27百万美元，同比减少177.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558068485","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558068485?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841698,"startTime":"0","endTime":"0","summary":"8月11日，Gossamer Bio, Inc.公布财报，公告显示公司2025财年第二财季净利润为-38.27百万美元，同比减少177.74%；其中营业收入为11.49百万美元，同比减少88.01%，每股基本收益为-0.17美元。机构评级：截至2025年8月11日，当前有7家机构对Gossamer Bio, Inc.目标价做出预测，其中目标均价为7.75美元，其中最低目标价为1.25美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000403a48057c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000403a48057c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS"],"gpt_icon":0},{"id":"2557305575","title":"Gossamer Bio, Inc.盘中异动 急速跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557305575","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557305575?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:42","pubTimestamp":1754491361,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时42分，Gossamer Bio, Inc.股票出现异动，股价急速跳水5.09%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Bioxcel Therapeutics, Inc.、Biomx Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为590.48%、349.63%、49.95%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为45.15%、44.74%、36.81%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224241a6d6d0b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806224241a6d6d0b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4505","BK4139"],"gpt_icon":0},{"id":"2556480811","title":"Gossamer Bio, Inc.盘中异动 大幅跳水5.15%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556480811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556480811?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:01","pubTimestamp":1754056885,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时01分，Gossamer Bio, Inc.股票出现波动，股价大幅跳水5.15%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Bioxcel Therapeutics, Inc.、天境生物涨幅较大，Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1010.98%、126.99%、125.50%，振幅较大的相关个股有Neurosense Therapeutics Ltd.、天境生物、Bioxcel Therapeutics, Inc.，振幅分别为36.34%、22.89%、22.14%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220125972d0d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220125972d0d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","GOSS"],"gpt_icon":0},{"id":"2555404727","title":"Gossamer Bio, Inc.盘中异动 急速拉升5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555404727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555404727?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:30","pubTimestamp":1753882239,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时30分，Gossamer Bio, Inc.股票出现波动，股价急速上涨5.36%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Replimune Group, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、Imunon, Inc.、Replimune Group, Inc.较为活跃，换手率分别为179.66%、78.66%、75.83%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Aclaris Therapeutics, Inc.、Upstream Bio, Inc.，振幅分别为36.81%、9.03%、8.02%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021304094c3f566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073021304094c3f566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2555910705","title":"Gossamer Bio, Inc.盘中异动 下午盘股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555910705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555910705?lang=zh_cn&edition=full","pubTime":"2025-07-29 01:46","pubTimestamp":1753724773,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日01时46分，Gossamer Bio, Inc.股票出现异动，股价大幅上涨5.43%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Celcuity Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Protagenic Therapeutics Inc C/Wts 26/04/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为535.73%、300.51%、132.25%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为158.93%、82.93%、75.48%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290146139723a4f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507290146139723a4f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GOSS","BK4139","BK4505"],"gpt_icon":0},{"id":"2552352514","title":"Gossamer Bio, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552352514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552352514?lang=zh_cn&edition=full","pubTime":"2025-07-18 01:30","pubTimestamp":1752773429,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日01时30分，Gossamer Bio, Inc.股票出现异动，股价快速上涨5.42%。Gossamer Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、180 Life Sciences Corp.涨幅较大，Windtree Therapeutics, Inc.、Marker Therapeutics, Inc.、180 Life Sciences Corp.较为活跃，换手率分别为965.58%、528.99%、324.09%，振幅较大的相关个股有Marker Therapeutics, Inc.、180 Life Sciences Corp.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为148.12%、96.60%、95.69%。Gossamer Bio, Inc.公司简介：Gossamer Bio Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718013029a45194ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718013029a45194ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","GOSS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gossamerbio.com","stockEarnings":[{"period":"1week","weight":0.0745},{"period":"1month","weight":-0.2732},{"period":"3month","weight":0.311},{"period":"6month","weight":0.4891},{"period":"1year","weight":1.9718},{"period":"ytd","weight":-0.1161}],"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0203},{"period":"6month","weight":0.0758},{"period":"1year","weight":0.1366},{"period":"ytd","weight":0.0051}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Gossamer Bio, Inc.于2015年10月26日根据特拉华州法律以FSG, Bio, Inc.的名字注册成立，并于2017年更名为Gossamer Bio, Inc.,Gossamer Bio, Inc.该公司是一家临床阶段的生物制药公司，专注于赛拉鲁替尼治疗肺动脉高压或PAH的开发和商业化。该公司的目标是成为行业领导者，并提高患有肺动脉高压或PH的患者的生活。为实现这一目标，该公司集结了一群经验丰富、技术精湛的行业资深人士、科学家、临床医生和来自领先生物技术和制药公司的关键意见领袖，以及来自世界各地的领先学术中心。该公司打算保持科学严谨和包容的企业文化，员工努力为患者带来更好的治疗选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.019795},{"month":2,"riseRate":0.333333,"avgChangeRate":0.072134},{"month":3,"riseRate":0,"avgChangeRate":-0.118499},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.093097},{"month":5,"riseRate":0.571429,"avgChangeRate":-0.004094},{"month":6,"riseRate":0.714286,"avgChangeRate":0.13683},{"month":7,"riseRate":0.571429,"avgChangeRate":0.129679},{"month":8,"riseRate":0.714286,"avgChangeRate":0.097398},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.027644},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.109871},{"month":11,"riseRate":0.571429,"avgChangeRate":0.095879},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.08654}],"exchange":"NASDAQ","name":"Gossamer Bio Inc.","nameEN":"Gossamer Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Gossamer Bio Inc.,GOSS,Gossamer Bio Inc.股票,Gossamer Bio Inc.股票老虎,Gossamer Bio Inc.股票老虎国际,Gossamer Bio Inc.行情,Gossamer Bio Inc.股票行情,Gossamer Bio Inc.股价,Gossamer Bio Inc.股市,Gossamer Bio Inc.股票价格,Gossamer Bio Inc.股票交易,Gossamer Bio Inc.股票购买,Gossamer Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Gossamer Bio Inc.(GOSS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Gossamer Bio Inc.(GOSS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况